NEW YORK - eTradeWire -- The Icla da Silva Foundation proudly honored Dr. Selwyn M. Vickers, President and CEO of Memorial Sloan Kettering Cancer Center (MSKCC), at its annual Hope Gala in New York City on October 14, 2025. Dr. Vickers, a distinguished surgeon and healthcare leader, was recognized for his dedication to advancing cancer care and his shared commitment to supporting patients throughout their treatment journey.

Though unable to attend the Foundation's annual Hope Gala, Dr. Vickers shared a video message underscoring the Foundation's importance in helping patients overcome barriers to life-saving bone marrow transplants.

"Cancer is an arduous journey, creating financial and emotional distress," Dr. Vickers said. "The Icla da Silva Foundation is an important partner in helping patients navigate this difficult journey by providing hope and support to patients in the midst of these stressful experiences."

Dr. Vickers emphasized the vital partnership between clinical care and the generosity and support that make treatment possible. The Foundation's mission—to remove barriers for patients scheduled to receive bone marrow transplants—complements MSK's clinical excellence by addressing the real-world challenges that patients face.

More on eTradeWire News

• Buy India Realty Notes Growing NRI Interest in Practical Mid-Segment Housing in India
• Free Pet Health App Launches in Australia to Support Families During School Holidays
• Crypto Corner Shop Becomes an Official U.S. LLC
• nodeB59 Unveils Digital Ecosystem at Bellefonte Cafe
• Two Mistakes to Avoid When Making a Public Liability Claim

https://youtu.be/yLCiwY8LqMA



His message concluded with a call to action for others to support the cause: "For all of you here tonight, you have a chance to both be generous and make a difference. I encourage you, like others, to contribute to the Icla da Silva Foundation."

Dr. Vickers's recognition reflects the shared commitment of medical institutions and nonprofit partners like the Icla da Silva Foundation, giving every patient the best possible chance at recovery.

About the Icla da Silva Foundation

The Icla da Silva Foundation is a 501(c)(3) nonprofit dedicated to helping patients in need receive bone marrow transplants. Founded in 1992, in memory of Icla da Silva, a 13-year-old girl who lost her life to leukemia, the Foundation supports patients scheduled to receive a transplant by removing barriers to care. With a focus on underserved communities, they provide financial, emotional, and logistical support from diagnosis to recovery.

Visit www.icla.org for more information.